Podcast Journal Club

Bisphosphonates and Atypical Femoral Fractures

June 20, 2024


Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center (right in photo below), in a discussion recorded in front of an audience at ENDO 2024 in Boston. He talks about a recent article in The Journal of Clinical Endocrinology & Metabolism with Amal Shibli-Rahhal, MD, from University of Iowa Carver College of Medicine (center in photo below), and guest expert Ghada El-Hajj Fuleihan, MD, from the American University of Beirut (left in photo below), along with four fellows who submitted questions ahead of time.

live recording of Endocrine Feedback Loop podcast episode 50

The article featured this month, by Bauer et al, was first published online in JCEM in January 2024: “Bisphosphonate Use and Risk of Atypical Femoral Fractures: A Danish Case-Cohort Study With Blinded Radiographic Review.”

Meet the Speakers

Ghada El-Hajj Fuleihan and Amal Shibli-Rahhal

Ghada El-Hajj Fuleihan, MD, MPH, is a professor of medicine at the American University of Beirut (AUB) in Lebanon. She served as founding director of the Calcium Metabolism Program at the Brigham and Women’s Hospital prior to moving to AUB. She is the founding director of the Calcium Metabolism and Osteoporosis Program and WHO Collaborating Center for Metabolic Bone Diseases and founding/program director of the NIH-funded Scholars in Health Research Program at AUB. She has served as associate dean of clinical research, founding director of the Clinical Research Institute and of the Human Research Protection Program at AUB. Dr. El-Hajj Fuleihan earned a bachelor’s degree and medical degree at AUB and completed her internship/residency in internal medicine at the New England Deaconess Hospital and her fellowship at Brigham and Women’s. Her research laboratory focuses on calcium-sensing and mineral metabolism. Her laboratory leads multicenter studies on osteoporosis epidemiology and clinical trials investigating the impact of vitamin D on skeletal and non-skeletal outcomes across the lifecycle. Her work is published in more than 165 manuscripts, peer reviewed protocols, nine invited editorials/commentaries, 18 position papers and clinical guidelines, 27 invited reviews, and 14 book chapters in major reference textbooks.

Amal Shibli-Rahhal, MD, MSc, MME, received her medical degree from the American University of Beirut and completed her post-graduate training in internal medicine and endocrinology at the University of Iowa. Dr. Shibli-Rahhal is professor and endocrinologist at the University of Iowa, where she also acts as the Associate Dean for Student Affairs and Curriculum at the University of Iowa Carver College of Medicine. Previously, Dr. Shibli-Rahhal acted as Endocrinology Fellowship Program Director, preclinical Course Director for the College of Medicine, and Associate Chief of Staff for Education at the Iowa City VA. In addition to her role as program director, Dr. Shibli-Rahhal also created and serves as director of the University of Iowa Metabolic Bone Clinic.

The fellows who provided questions are David Berger, MD, from Columbia University; Camila Villavicencio, MD, from the Mayo Clinic; Mazin Al-Maghrabi from McGill University; and Lipi Marion, MD, from Massachusetts General Hospital.



Stay up to date by copying this link into your podcast player or:

Apple Podcasts

Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.